People

Alexza Pharmaceuticals has announced the hire of Robert A. Lippe as Executive VP, Operations and Chief Operations Officer. Lippe was most recently Head of Global Operations & Operational Excellence at Ironwood Pharmaceuticals. The company is in the process of commercializing its Adasuve Staccato inhaled loxapine, which began its launch in Europe in the summer of … [Read more...] about Alexza hires Robert A. Lippe to head operations

Lupin Pharmaceuticals has announced that Maurice Chagnaud has joined the company as President, Europe and Head of Inhalation Strategy. He was most recently Senior Vice President, Central & Eastern Europe at Teva. Chagnaud's responsibilities will include Lupin's European business as well as the company's "core strategy for inhalation in the developed markets." Lupin … [Read more...] about Maurice Chagnaud to develop Lupin’s inhalation strategy

Civitas Therapeutics has announced that former Sunovion CEO Mark Iwicki will succeed Glenn Batchelder as President and Chief Executive Officer. Iwicki was most recently CEO of Blend Therapeutics. According to Civitas, which is developing inhaled drugs based on its proprietary ARCUS particle manufacturing and delivery platform, Batchelder will continue to serve on the … [Read more...] about Mark Iwicki named President and CEO of Civitas

Evoke Pharma has appointed Marilyn Carlson as Chief Medical Officer and Wayne Alves as Senior Director of Clinical Operations. The company is planning to begin a Phase 3 clinical trial of EVK-001 intranasal metoclopramide for gastroparesis, which is expected to commence in the first half of 2014. Evoke President and CEO Dave Gonyer said, "Dr. Carlson and Dr. Alves … [Read more...] about Evoke Pharma adds executives as gastroparesis nasal spray moves into Phase 3

Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm's inhaled ciprofloxacin formulations, Pulmaquin and Lipoquin, were licensed by Grifols earlier this year. Aradigm … [Read more...] about Aradigm appoints Juergen Froehlich new chief medical officer

MDI component manufacturer Presspart has announced a round of changes to its management team. According to the company, Hans Neugebauer, who is currently Managing Director of Presspart Marsberg, will become Managing Director of Presspart Blackburn as of January 1, 2014. At that time, Dietmar Schmitz will return to his former position as the Presspart group Chief … [Read more...] about Management changes at Presspart

Meda, whose products include several nasal sprays and inhalers, has announced that Jörg-Thomas Dierks will replace Anders Lönner as CEO after Lönner decided to step down. Dierks joined Meda in 2005 and had served as Chief Operating Officer since then. Meda Chairman of the Board Bert Åke Eriksson said, “Anders Lönner has done outstanding work during his last 14 … [Read more...] about New CEO for Meda

According to the Allergy & Asthma Network Mothers of Asthmatics (AANMA), President and Founder Nancy Sander has retired. Sander founded the patient advocacy organization in 1985. Over the course of her tenure with AANMA, Sander advocated for legal and regulatory changes to benefit asthma patients, including the FDA guidance for dose counters on inhalers. … [Read more...] about AANMA President Nancy Sander retires

Smartinhaler manufacturer Nexus6 has announced three new management appointments: Veronique Bouchet as VP of Business Development for Europe, Christopher Stevens as Chief Operating Officer, and Chris Mander as Head of Regulatory and Quality. According to the company, increased demand for its inhaler monitoring systems necessitated the expansion of its global … [Read more...] about Nexus6 announces three new hires